Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950725 · ClinicalTrials.gov registry record · NA
Covid-19 Virtual Recovery Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 2,268
- Enrollment target
NCT04950725: Completed NA study, sponsored by Mayo Clinic.
NCT04950725 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 2,268 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04950725, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,268 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.
Primary Outcome
Speaking/ speech sounds
Interventions
- BEHAVIORAL Strength RMT
- BEHAVIORAL Strength RMT and nasal breathing
- BEHAVIORAL Endurance RMT
- BEHAVIORAL Endurance RMT and nasal breathing
- BEHAVIORAL Low dose RMT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,268 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
What the finished NCT04950725 record still lists
NCT04950725 is an interventional study that assigns participants to a tested intervention. Its 2,268 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (62% higher).
The record links to 0 conditions, and to 5 interventions - of which Strength RMT is the first listed.
NCT04950725 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04950725 about?
NCT04950725 is a clinical study titled "Covid-19 Virtual Recovery Study". The purpose of this study is to determine the effects of respiratory muscle training (RMT) and nasal breathing on patients who have been infected with the SARS-CoV2 virus and continue to have lingering symptoms.
What is the current status of trial NCT04950725?
This trial is currently completed. It is a NA study. The enrollment target is 2,268 participants. The study started on 2021-11-01. Estimated completion is 2023-07-01.
What interventions are being tested in trial NCT04950725?
The interventions under investigation include: Strength RMT (BEHAVIORAL), Strength RMT and nasal breathing (BEHAVIORAL), Endurance RMT (BEHAVIORAL), Endurance RMT and nasal breathing (BEHAVIORAL), Low dose RMT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04950725?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04950725's enrollment target sits among peer trials
2,268 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT05530343 · 2,298 participants · NA
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI